Skip to content
Live
Market Cap:$2.32T+1.17%
24h Vol:$71.4B
BTC:56.5%
ETH:10%
Coins:17,674
Updated 05:28 AM
Injective

Injective

INJ
Kekius Maximus
Kekius Maximus
KEKIUS

Fundamental comparison between Injective and Kekius Maximus

Not Financial Advice

This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →

Injective

Injective

71
050100
Undervalued
24h+4.90%
7d-7.90%
Kekius Maximus

Kekius Maximus

45
050100
Fair Value
24h-3.10%
7d-21.10%

Detailed Comparison

MetricInjectiveKekius Maximus
Price$4.81$0.020243
Market Cap$480.89M$20.25M
24h Volume61.9M6.6K
Rank#—#—
Circulating Supply100M1B
ATH$52.62$0.055335

Injective vs Kekius Maximus — Analysis

Injective and Kekius Maximus are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.

Value Score Comparison

With a Value Score of 70.7, Injective is currently rated as "undervalued", while Kekius Maximus scores 45 and is rated "fair value". This means our algorithm considers Injective the fundamentally stronger investment — with a significant gap of 25.700000000000003 points.

Injective has the higher Value Score (70.7/100)

Market Cap & Risk

Injective has a 24x larger market capitalization than Kekius Maximus. A larger market cap typically means less volatility but also less growth potential. Kekius Maximus may offer more upside but comes with higher risk.

Price Performance

Over the last 24 hours, Injective moved 4.90%, while Kekius Maximus changed -3.10%. Looking at the 7-day window, Injective is at -7.90% and Kekius Maximus at -21.10%.

Distance from All-Time High

Injective currently trades at 9% of its all-time high ($52.62), while Kekius Maximus sits at 37% of its ATH ($0.055335). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.

Conclusion

Based on our fundamental analysis, Injective (Score: 70.7) currently has a stronger investment case than Kekius Maximus (Score: 45). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.

Trezor Safe 5 — Secure your crypto